Press Releases | Medtronic

Month Year

Email alerts

Apr 19, 2011

Medtronic Introduces the MARROWMAX(TM) Bone Marrow Aspiration Needle Kit

Product complements Medtronic's Biologics and bone grafting portfolio

MEMPHIS, Tenn., Apr 19, 2011 (BUSINESS WIRE) -- Expanding its leading bone grafting portfolio, Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of the MARROWMAX(TM) Bone Marrow...
Apr 18, 2011

Medtronic Launches New, Enhanced Midas Rex e-Institute(R) Website for Residents, Surgeons, and Healthcare Staff

New Site Offers Unrestricted Access to Interactive Learning

MINNEAPOLIS, Apr 18, 2011 (BUSINESS WIRE) -- Medtronic, Inc.(NYSE: MDT) today announced the launch of its new Midas Rex e-Institute(R) website (www.e-institute.com), an enhanced web portal for...
Apr 11, 2011

Medtronic Launches More Accurate and Comfortable Sensor to Help Improve Glucose Contro

Enlite(TM) SensorAvailable to Diabetes Patients for Continuous Glucose Monitoring in More Than 35 Countries

MINNEAPOLIS, Apr 11, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announces the launch of Enlite(TM) Sensor, the newest and most advanced glucose sensor for continuous glucose monitoring...
Apr 7, 2011

Medtronic to Form a Single, Unified U.S. Cardiac and Vascular Group Sales Organization

New Structure Uniquely Positions Medtronic to Maintain Focus on Clinicians While Addressing the Needs of Cardiac and Vascular-focused Hospital Administrators

MINNEAPOLIS, Apr 07, 2011 (BUSINESS WIRE) -- Responding to the challenges hospitals face in the changing healthcare environment, as well as the increasing importance of the hospital administrator...
Apr 4, 2011

Medtronic Resolute(R) Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies

Across Spectrum of Patients with Coronary Artery Disease, Novel Heart Device Shows Strong Results at One Year in RESOLUTE US and Two Years in RESOLUTE All Comers

NEW ORLEANS, Apr 04, 2011 (BUSINESS WIRE) -- Results of two major clinical studies presented at ACC.11 - the 60th Annual Scientific Session & Expo of the American College of Cardiology (ACC) -...
Apr 4, 2011

Medtronic Announces Mac Compatibility for CareLink(R) Personal Therapy Management Software for Diabetes

Software Helps Users Identify Low and High Glucose Levels

MINNEAPOLIS, Apr 04, 2011 (BUSINESS WIRE) -- Medtronic, Inc. today announced the Food and Drug Administration (FDA) approval and the market launch of CareLink(R) Personal 5.4 Therapy Management...
Apr 4, 2011

Landmark IMPROVE HF Study Shows Adherence to Outpatient Quality Measures Associated with Improved Survival in Heart Failure Patients

Study Published Today in Circulation is the First to Assess the Correlation of Seven Heart Failure Process-Based Quality Measures with Clinical Outcomes

MINNEAPOLIS, Apr 04, 2011 (BUSINESS WIRE) -- Results from the largest U.S. outpatient heart failure clinical study, published today in the journal Circulation and funded by Medtronic, Inc. (NYSE:...
Apr 1, 2011

Medtronic Announces FDA Approval of InterStim(R) Therapy for Bowel Control

Unique Sacral Nerve Stimulation Therapy Now Available for Treatment of Chronic Fecal Incontinence

MINNEAPOLIS, Apr 01, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of InterStim(R) Therapy for Bowel Control. InterStim...
Mar 28, 2011

Medtronic to Unveil Pivotal U.S. Data on Resolute(R) Drug-Eluting Stent at ACC.11

Late-Breaking Clinical Trials Feature One-Year Results of RESOLUTE US Study; Latest Evidence from Comprehensive Research Program Completes FDA Approval Submission

MINNEAPOLIS, Mar 28, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), today announced the imminent release of the pivotal U.S. data on its Resolute(R) drug-eluting stent (DES) at ACC.11, the 60th
Mar 28, 2011

Medtronic Announces FDA Approval of Protecta(TM) Implantable Defibrillators That Reduce Inappropriate Shocks

New Implantable Cardiac Devices with SmartShock(TM) Technology Enhance Patient Quality of Life

MINNEAPOLIS, Mar 28, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Protecta(TM)portfolio of implantable...

Show per page